Results 131 to 140 of about 9,316 (206)

NTRK1/TPM3 Fusion Gene [PDF]

, 2020
openaire   +1 more source

Prognostic relevance of secondary actionable fusions in MLH1-deficient dMMR/MSI-H gastrointestinal tumors treated with pembrolizumab. [PDF]

ESMO Gastrointest Oncol
Martínez Lago N, Sánchez Ares M, Carral Maseda A, Pérez Martelo M, Covela Rúa M, Fernández Montes A, de la Cámara Gómez J, González Villarroel P, Reboredo López M, Padín Iruegas ME, Abdulkader Nallib I.   +10 more
europepmc   +1 more source

Glioblastoma, <i>IDH-</i>wildtype, with a novel <i>MEF2D-NTRK1</i> gene fusion: a case report. [PDF]

Front Oncol
Dewey A, Baranda JC, Zhang W, Haeri M, Milligan B, Tuncer T.   +5 more
europepmc   +1 more source

<i>RET</i> fusion partners dictate oncogenic potential in undifferentiated spindle cell sarcomas. [PDF]

Cancer Biol Ther
Gui Q, Zhang Y, Yang M, Liang R, Huang M, Yang X, Chen N, Chen X, Wu M, Chen H, Meng L, Xiao S, Tao M.   +12 more
europepmc   +1 more source

Detection of NTRK gene fusions in sarcomas: a comparative study of Pan-TRK immunohistochemistry, FISH, and RNA-Based NGS. [PDF]

Pathologica
Cocchi S, Gambarotti M, Gamberi G, Magagnoli G, Maioli M, Parra A, Sciulli E, Ibrahim T, Righi A, Benini S.   +9 more
europepmc   +1 more source

Real-World Outcomes of Fusion-Directed Targeted Therapy in Advanced Non-Small Cell Lung Cancer Harboring Actionable Gene Fusions. [PDF]

Int J Mol Sci
Delgado Leon F, de Armas SA, Molina M, Morales EG, Fernandez-Gomez M, Raez LE.   +5 more
europepmc   +1 more source

TPR/NTRK1 Fusion Gene TRKT1 [PDF]

, 2020
openaire   +1 more source

Early clinical diagnosis of congenital insensitivity to pain with anhidrosis in an infant: a case report. [PDF]

Front Pediatr
Tang Z, Xu F, Zhang P, Zhang J, Kang X, Zhao H.   +5 more
europepmc   +1 more source

Dermoscopic Features of Spitz Tumor With LMNA-NTRK1 Fusion

Dermatology Practical & Conceptual, 2020
Ben J. Friedman, Gabrielle Robinson, Laurie Kohen   +2 more
openaire   +4 more sources

ETV6-NTRK3 as a resistance mechanism to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: favorable response after combination of osimertinib and entrectinib: a case report and literature review. [PDF]

Front Pharmacol
Xie W, Luo H, Wang H, Shi G, Tang J, Ma L, Zhou J.   +6 more
europepmc   +1 more source